Buscar
Mostrando ítems 1-10 de 247
Clinical and haemodynamic evaluation of chronic thromboembolic pulmonary hypertension patients scheduled for pulmonary thromboendarterectomy: Is schistosomiasis hypertension an important confounding factor?
(Faculdade de Medicina / USP, 2010)
INTRODUCTION: Chronic thromboembolic pulmonary hypertension is a disease affecting approximately 4,000 people per year in the United States. The incidence rate in Brazil, however, is unknown. The estimated survival for ...
Measurement, interpretation and use of hemodynamic parameters
(CAMBRIDGE UNIV PRESS, 2009)
Hemodynamic effects of combined sildenafil and L-arginine during acute pulmonary embolism-induced pulmonary hypertension
(Elsevier B.V., 2005-11-07)
Sildenafil attenuates acute pulmonary embolism-induced pulmonary hypertension. However, the hemodynamic effects of sildenafil in combination with other vasodilators during acute pulmonary embolism have not been examined ...
Sildenafil selectively inhibits acute pulmonary embolism-induced pulmonary hypertension
(Academic Press Ltd Elsevier Science LtdLondonInglaterra, 2005)
Losartan exerts no protective effects against acute pulmonary embolism-induced hemodynamic changes
(SPRINGERNEW YORK, 2012)
The acute obstruction of pulmonary vessels by venous thrombi is a critical condition named acute pulmonary embolism (APE). During massive APE, severe pulmonary hypertension may lead to death secondary to right heart failure ...
Caracterización clínica, funcional y hemodinámica de la población con hipertensión pulmonar arterial evaluada en el Instituto Nacional del Tórax
(Sociedad Médica de Santiago, 2006)
Hemodynamic effects of combined sildenafil and L-arginine during acute pulmonary embolism-induced pulmonary hypertension
(Elsevier Science BvAmsterdamHolanda, 2005)